Umbilical Cord Blood Natural Killer Cells, Their Characteristics, and Potential Clinical Applications.

about

Human Pluripotent Stem Cells to Produce Cell-based Cancer Immunotherapy.Anticancer cellular immunotherapies derived from umbilical cord blood.Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies

P2860

Q46350666-B7E266AD-249A-4E4F-807F-3B67629027F8 Q47657491-9230BA38-DEA1-4678-A104-A0332F47ED3F Q57300237-52A4890A-7590-4AA5-BC88-8A5FE2D3394F

P2860

Umbilical Cord Blood Natural Killer Cells, Their Characteristics, and Potential Clinical Applications.

Item

http://www.wikidata.org/entity/Q38733830

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Umbilical Cord Blood Natural K ...... tential Clinical Applications.

@en

type

Item

label

Umbilical Cord Blood Natural K ...... tential Clinical Applications.

@en

prefLabel

Umbilical Cord Blood Natural K ...... tential Clinical Applications.

@en

P1476

Umbilical Cord Blood Natural K ...... otential Clinical Applications

@en

P2093

Anushruti Sarvaria

http://www.w3.org/2001/XMLSchema#string

Aurore Saudemont

http://www.w3.org/2001/XMLSchema#string

P2860

Natural killer cells generated from cord blood hematopoietic progenitor cells efficiently target bone marrow-residing human leukemia cells in NOD/SCID/IL2Rg(null) mice

High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy

KIR: diverse, rapidly evolving receptors of innate and adaptive immunity

Clinical-grade generation of active NK cells from cord blood hematopoietic progenitor cells for immunotherapy using a closed-system culture process

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1, and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia

Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein.

Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation

P304

329

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2017.00329

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dunia Jawdat

A Madrigal

P577

2017-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28386260

http://www.w3.org/2001/XMLSchema#string

P932

5362597

http://www.w3.org/2001/XMLSchema#string

Umbilical Cord Blood Natural Killer Cells, Their Characteristics, and Potential Clinical Applications.

about

P2860

P2860

Umbilical Cord Blood Natural Killer Cells, Their Characteristics, and Potential Clinical Applications.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932